G730-1306 Screening compound: N~8~-(2-methylphenethyl)-3,4-dihydro-1H-[1,4]oxazino[4,3-a][1,3]benzimidazole-8-carboxamide

G730-1306 Screening compound: N~8~-(2-methylphenethyl)-3,4-dihydro-1H-[1,4]oxazino[4,3-a][1,3]benzimidazole-8-carboxamide
G730-1306 Screening compound: N~8~-(2-methylphenethyl)-3,4-dihydro-1H-[1,4]oxazino[4,3-a][1,3]benzimidazole-8-carboxamide alternative view

Chemical Structure Depiction of ChemDiv screening compound G730-1306
N~8~-(2-methylphenethyl)-3,4-dihydro-1H-[1,4]oxazino[4,3-a][1,3]benzimidazole-8-carboxamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

G730-1306

Molecular Formula

C20H21N3O2 (C20 H21 N3 O2)

Compound Name

N~8~-(2-methylphenethyl)-3,4-dihydro-1H-[1,4]oxazino[4,3-a][1,3]benzimidazole-8-carboxamide

IUPAC name

N-[2-(2-methylphenyl)ethyl]-11-oxa-18-diazatricyclo[7.4.0.0^{27}]trideca-2(7)358-tetraene-5-carboxamide

SMILES

Cc1c(CCNC(c(cc2)cc3c2n(CCOC2)c2n3)=O)cccc1

InChI

InChI=1S/C20H21N3O2/c1-14-4-2-3-5-15(14)8-9-21-20(24)16-6-7-18-17(12-16)22-19-13-25-11-10-23(18)19/h2-7,12H,8-11,13H2,1H3,(H,21,24)

InChI Key

VVNJVLYLGZNCQJ-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD15030722

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

335.41

Hydrogen Bond Acceptors Count

4.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

5.00

Number of Nitrogen and Oxygen Atoms

5

Partition Coefficient, logP

2.958

Distribution Coefficient, logD

2.957

Water Solubility, LogSw

-3.17

Polar Surface Area

44.101

Acid Dissociation Constant (pKa)

13.12

Base Dissociation Constant (pKb)

4.43

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

30.00

G730-1306 in Drug Discovery

Included in Screening Libraries

Anti-Aging Library (44940 compounds)

Antiviral Annotated Library (21441 compounds)

300k Representative Compounds Library (Bemis-Murcko Clustering Algorithm) (286253 compounds)

CNS targets activity set (6557 compounds)

ChemoGenomic Annotated Library for Phenotypic Screening (89798 compounds)

Epigenetics Focused Set (26518 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Musculoskeletal
  • Metabolic
  • Immune system
Mechanism of action:
  • Epigenetic

References: we are preparing a list of scientific research reports with G730-1306 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound G730-1306?
Check Price and Availability of G730-1306, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of G730-1306 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for G730-1306
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for G730-1306
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of G730-1306 available by request